IGF-1 LR3 Protocol

The Growth Factor

A long-acting insulin-like growth factor studied for its potential role in muscle cell proliferation, recovery, and lean tissue support. Researched in comparison to standard GH protocols.

IGF-1 LR3 has been studied in relation to muscle growth, recovery, and performance. Some research suggests it may support lean tissue development and workout recovery. Results depend on individual patient profile and are assessed by your prescribing physician.

What is IGF-1 LR3?

IGF-1 LR3 (Insulin-like Growth Factor-1 Long R3) is a modified analogue of natural IGF-1 with an extended half-life compared to the native form. IGF-1 is a hormone produced by the liver in response to growth hormone signalling and plays a central role in cellular growth, metabolism, and tissue repair. The LR3 modification extends its activity period, making it a subject of interest in muscle physiology and recovery research. In the UAE, IGF-1 LR3 requires a physician prescription and is available through UAE Peptide Clinic.

IGF-1 LR3 in research

Research into IGF-1 LR3 has focused primarily on skeletal muscle, including its potential to promote satellite cell activation important for muscle growth and repair, protein synthesis, and recovery after training or injury. Studies have also explored its relationship with fat metabolism and body composition. IGF-1 LR3 is one of the more potent peptides in the growth factor category and requires careful physician-directed dosing; it is not appropriate for all patients.

IGF-1 LR3 in the UAE

Active patients in Dubai, including competitive athletes and fitness-focused individuals, have explored IGF-1 LR3 as part of performance and body composition protocols. UAE Peptide Clinic prescribes IGF-1 LR3 only following a full physician consultation that includes a review of baseline IGF-1 blood levels, overall health status, and goals. Standard protocols involve doses of 20 to 50 mcg per day for 4 to 6 week cycles with extended break periods.